tiprankstipranks
Trending News
More News >
Livzon Pharmaceutical Group Inc Class H (HK:1513)
:1513
Hong Kong Market
Advertisement

Livzon Pharmaceutical Group (1513) Drug Pipeline

Compare
1 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
H001 Capsule 200Mg-Qd, Enoxaparin Sodium Injection, H001 Capsule 300Mg-Qd, H001 Capsule 200Mg-Bid
Circulatory Disease
Phase II
Recruiting
Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty
Apr 30, 2025
Jp-1366 Simulation Tablets, Esomeprazole Magnesium (Nexium) Simulation Tablets
Reflux Esophagitis (Re)
Phase III
Recruiting
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis
Feb 07, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Livzon Pharmaceutical Group Inc Class H (1513) have in its pipeline
      1513 is currently developing the following drugs: H001 Capsule 200Mg-Qd, Enoxaparin Sodium Injection, H001 Capsule 300Mg-Qd, H001 Capsule 200Mg-Bid, Jp-1366 Simulation Tablets, Esomeprazole Magnesium (Nexium) Simulation Tablets. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis